Single dose imipramine reduces nocturnal urine output in patients with nocturnal enuresis and nocturnal polyuria.
OBJECTIVE
We investigated the effect of imipramine on nocturnal urine output in patients with nocturnal enuresis.


METHODS
There were 15 monosymptomatic enuretic patients 15 to 37 years and 8 control subjects 25 to 32 years old. We measured nocturnal urine output, urine osmolality, creatinine clearance, osmolal clearance, free water clearance, excretion of solutes, fractional excretion of sodium, fractional excretion of potassium and plasma vasopressin with and without a single oral dose of imipramine (1 mg./kg. of body weight) taken at 8 p.m.


RESULTS
Baseline studies showed significantly larger and less concentrated nocturnal urine among enuretics compared with controls. We observed a marked antidiuretic effect of imipramine in 6 enuretics with severe nocturnal polyuria. The imipramine induced decrease in urine output was accompanied by reduced osmolal clearance. Approximately a third of the observed decrease in solute excretion was attributed to lower excretion of sodium and potassium. The remaining two-thirds were most likely caused by an increased tubular reabsorption of urea, which may be secondary to a sympathomimetic effect of imipramine tubules, possibly because of altered adrenal medullary function with an increase in proximal tubular sodium and water reabsorption. The resultant lower tubular flow rate facilitates tubular reabsorption of urea in the distal part of the nephron.


CONCLUSIONS
Imipramine has a vasopressin independent antidiuretic effect if nocturnal polyuria is present. The antidiuretic effect of imipramine can be attributed primarily to increased alpha-adrenergic stimulation in the proximal tubules with a secondary increased urea and water reabsorption more distally in the nephron.
Hunsballe
J M
JM
International Enuresis Research Center, University of Aarhus, Aarhus University Hospital, Denmark.
Rittig
S
S
Pedersen
E B
EB
Olesen
O V
OV
Djurhuus
J C
JC
D000293:Adolescent; D000328:Adult; D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage*; D004775:Enuresis / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D006801:Humans; D007099:Imipramine / Q000008:administration & dosage*; D008297:Male; D011141:Polyuria / Q000188:drug therapy* / Q000378:metabolism; D014556:Urine
D000929:Antidepressive Agents, Tricyclic; D007099:Imipramine